Song MF, Ma LY, Zhao Q, Shen C, Zhao CY. [Research progress on the mechanism and response strategies of molecular targeted drug resistance in liver cancer].
Zhonghua Gan Zang Bing Za Zhi 2023;
31:1108-1112. [PMID:
38016782 DOI:
10.3760/cma.j.cn501113-20220723-00393]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 11/30/2023]
Abstract
Molecular targeted drugs are one of the treatments for hepatocellular carcinoma (HCC), the primary factor influencing their therapeutic efficacy is drug resistance. Diminished drug intake, greater efflux, improved DNA damage repair capacity, aberrant signal pathways, hypoxia, epithelial-mesenchymal cell transition, and the cellular autophagy system are summarized herein as aspects of the drug resistance mechanism. Simultaneously, effective strategies for addressing drug resistance are elaborated, providing ideas for better clinical treatment of HCC.
Collapse